Search research articles
Contact Us
Filters
Showing results (221-230 of 253) with videos related to
Page
of 26
Sort By:
Cancers
|
February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients
Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 26, 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer
Pier Paolo Avolio, Ronald Kool, Bobby Shayegan, et al.
European Urology Focus
|
November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers
Alice Dragomir, Sara Nazha, Simon Tanguay, et al.
European Urology Oncology
|
December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
Ghady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
The Journal of Urology
|
July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer
Daniel Halstuch, Ronald Kool, Gautier Marcq, et al.
The Oncologist
|
August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell Carcinoma
Manon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system
Ryan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
Clinical Genitourinary Cancer
|
March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration
Jesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 17, 2025
Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian study
David-Dan Nguyen, Paola V Nasute Fauerbach, Jethro C C Kwong, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 253) with videos related to
Sort By:
Page
of 26
Cancers
|
February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients
Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 26, 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer
Pier Paolo Avolio, Ronald Kool, Bobby Shayegan, et al.
European Urology Focus
|
November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers
Alice Dragomir, Sara Nazha, Simon Tanguay, et al.
European Urology Oncology
|
December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
Ghady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
The Journal of Urology
|
July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer
Daniel Halstuch, Ronald Kool, Gautier Marcq, et al.
The Oncologist
|
August 4, 2025
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary Renal Cell Carcinoma
Manon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system
Ryan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
Clinical Genitourinary Cancer
|
March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration
Jesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 17, 2025
Development of a reoperative risk prediction model of muscle-invasive upper tract urothelial carcinoma using clinical and radiomic computed tomography features: Initial results from a multi-institutional Canadian study
David-Dan Nguyen, Paola V Nasute Fauerbach, Jethro C C Kwong, et al.
Page
of 26